More stats from the investor presentation i can't stop reading:
- 22.5m telehealth visits annually (2015) for respiratory disease -just in the USA - this is growing at 56%/year.... Yes 56%.
-13.4m emergency department visits are for respiratory disease- just in the USA.
- 151m cases of Pneumonia in developing countries.
And to think our only real competitors are a stethoscope (developed in 1820s) & an X-ray, both more expensive and less accurate.
Lets hope all the people who lost on TON today can come over and recoup their losses on RAP.
- Forums
- ASX - By Stock
- RAP
- Ann: Breakthrough Performance in Paediatric Clinical Study
Ann: Breakthrough Performance in Paediatric Clinical Study, page-118
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries